FDA warns Johnson & Johnson on antibiotic trials

Novartis leukemia drug gets faster FDA review
Novartis AG said Friday its leukemia drug candidate Tasigna received priority review by the Food and Drug Administration.

FDA questions data for J&J ovarian cancer drug
Food and Drug Administration scientists are questioning whether study results are reliable enough to warrant approval for a new cancer drug from Johnson & Johnson.

Discovery faces further FDA delays on Surfaxin
Discovery Laboratories Inc. said Wednesday the Food and Drug Administration will apply a new standard to the company's respiratory drug candidate application, likely further holding up...

BlueAnt UNOTPBAX53 X5 Bluetooth Stereo Headphone...
The X5 Stereo Bluetooth Headset is a portable multi-function device utilizing the latest cutting edge technologies allowing you to stream high quality music and make voice calls using a...

Uniden TRU9496 2-Line Corded/Cordless Digital...
With the Uniden TRU9496 5.8 GHz Digital 2-Line Expandable Phone System is the next generation of 5.8 GHz cordless phones. It's a full-featured digital answerer, with a Dialing keypad and a...